ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -16.7% | 50,000 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $12,000 | -64.7% | 50,000 | -18.0% | 0.00% | -33.3% |
| Q4 2021 | $34,000 | -27.7% | 61,000 | +32.6% | 0.00% | -40.0% |
| Q3 2021 | $47,000 | -17.5% | 46,000 | +12.2% | 0.01% | -16.7% |
| Q2 2021 | $57,000 | +32.6% | 41,000 | +60.8% | 0.01% | 0.0% |
| Q1 2021 | $43,000 | +38.7% | 25,500 | +2.0% | 0.01% | +50.0% |
| Q4 2020 | $31,000 | +10.7% | 25,000 | +25.0% | 0.00% | -20.0% |
| Q3 2020 | $28,000 | +16.7% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $24,000 | 0.0% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $24,000 | -31.4% | 20,000 | +100.0% | 0.01% | -33.3% |
| Q1 2019 | $35,000 | +52.2% | 10,000 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $23,000 | -72.0% | 10,000 | -59.0% | 0.01% | -69.6% |
| Q2 2018 | $82,000 | – | 24,393 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |